Results for tag: "Kawasaki Disease Drug"

Kawasaki Disease (KD) is an immune disorder that affects children, primarily those under the age of five. It is characterized by inflammation of the blood vessels, which can lead to serious complications such as heart damage. Treatment for KD typically involves the use of immune-modulating drugs, such as intravenous immunoglobulin (IVIG) and high-dose aspirin. These drugs are used to reduce inflammation and prevent complications. The Kawasaki Disease Drug market is a subset of the larger Immune Disorders Drugs market. It is composed of drugs used to treat KD, such as IVIG and high-dose aspirin. These drugs are typically administered intravenously or orally, depending on the severity of the condition. The Kawasaki Disease Drug market is highly competitive, with many companies offering products for the treatment of KD. Some of the major players in the market include Pfizer, Merck, Sanofi, and Novartis. Other companies, such as Shire, CSL Behring, and Grifols, also offer products for the treatment of KD. Show Less Read more